Seres Therapeutics, Inc. (MCRB)
2.09
-0.04
(-1.88%)
USD |
NASDAQ |
Oct 23, 16:00
2.10
+0.01
(+0.48%)
After-Hours: 20:00
Seres Therapeutics Price to Book Value : 0.5948 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.5948 |
| October 22, 2026 | 0.6062 |
| October 21, 2026 | 0.6545 |
| October 20, 2026 | 0.6574 |
| October 19, 2026 | 0.6887 |
| October 16, 2026 | 0.7001 |
| October 15, 2026 | 0.72 |
| October 14, 2026 | 0.6887 |
| October 13, 2026 | 0.72 |
| October 12, 2026 | 0.7627 |
| October 09, 2026 | 0.7712 |
| October 08, 2026 | 0.7484 |
| October 07, 2026 | 0.7741 |
| October 06, 2026 | 0.8253 |
| October 05, 2026 | 0.811 |
| October 02, 2026 | 0.8367 |
| October 01, 2026 | 0.8338 |
| September 30, 2026 | 0.9533 |
| September 29, 2026 | 0.9903 |
| September 28, 2026 | 1.002 |
| September 25, 2026 | 1.002 |
| September 24, 2026 | 1.030 |
| September 23, 2026 | 1.078 |
| September 22, 2026 | 1.144 |
| September 21, 2026 | 1.158 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.138 |
| September 17, 2026 | 1.167 |
| September 16, 2026 | 1.198 |
| September 15, 2026 | 1.309 |
| September 14, 2026 | 1.346 |
| September 11, 2026 | 1.426 |
| September 10, 2026 | 1.451 |
| September 09, 2026 | 1.503 |
| September 08, 2026 | 1.582 |
| September 04, 2026 | 1.628 |
| September 03, 2026 | 1.605 |
| September 02, 2026 | 1.577 |
| September 01, 2026 | 1.474 |
| August 31, 2026 | 1.397 |
| August 28, 2026 | 1.454 |
| August 27, 2026 | 1.409 |
| August 26, 2026 | 1.355 |
| August 25, 2026 | 1.423 |
| August 24, 2026 | 1.326 |
| August 21, 2026 | 1.298 |
| August 20, 2026 | 1.300 |
| August 19, 2026 | 1.332 |
| August 18, 2026 | 1.235 |
| August 17, 2026 | 1.283 |
| August 14, 2026 | 1.292 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.32 |
| Anika Therapeutics, Inc. | 2.088 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.376 |
Price to Book Value Related Metrics
| PS Ratio | 10.45 |
| PEG Ratio | -0.0041 |
| Price | 2.09 |
| Earnings Yield | -109.0% |
| Market Cap | 20.54M |
| PEGY Ratio | -0.0041 |